- This scoping review of 130 studies, mostly observational cohorts (83.8%), mapped literature on chronic preoperative benzodiazepine use and perioperative outcomes.
- Chronic use was defined inconsistently, ranging from 1 month to over 1 year before surgery, and duration was not systematically defined in 47.7% of studies.
- Postoperative opioid use (40.8% of studies) and delirium or cognitive impairment (14.6%) were the most examined outcomes, with most reporting adverse associations.
- The authors conclude chronic use is a clinically relevant but inconsistently defined exposure, and that causal inference is not possible without risk-of-bias assessment and prospective studies.
Neuro
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This state-of-the-art review covers delirium epidemiology, mechanisms, diagnosis, prevention and treatment across cardiovascular medicine, drawing on interdisciplinary expert input.
- It identifies risk factors such as advanced age, baseline cognitive impairment, cerebrovascular disease, longer operative times, complications and systemic inflammation.
- Non-pharmacological multicomponent prevention is described as strongly supported, while preventive pharmacologic use remains controversial; dexmedetomidine is noted for ICU settings.
- The authors conclude that systematic risk assessment and multimodal prevention should be standard care, with more high-quality studies needed for cardiovascular-specific guidelines.
- Scoping review (PRISMA-ScR) of 48 included studies from 1,342 screened, mostly US-based and retrospective (43/48).
- Included studies examined GLP-1 receptor agonist exposure in adults with spinal, intracranial, or cerebrovascular disease, grouped into three themes.
- Spinal fusion studies repeatedly linked perioperative exposure to lower pseudarthrosis, though some reported more postoperative complications; IIH studies linked it to lower papilledema and shunt placement.
- The authors judge benefit signals most consistent in spinal fusion and IIH, but adverse effects and database overlap limit causal inference, and they call for prospective trials.
- Meta-analysis of 22 RCTs including 4161 older surgical patients under general anesthesia, searched across PubMed, Embase and CENTRAL through July 2026.
- Compared perioperative intravenous dexmedetomidine with control for prevention of postoperative delirium, the primary outcome.
- Dexmedetomidine reduced postoperative delirium (RR 0.56, 95% CI 0.47 to 0.66; P<0.00001; I² 24%) and PONV (RR 0.79, 95% CI 0.62 to 0.99; P=0.04).
- Dexmedetomidine was associated with more intraoperative and postoperative bradycardia and more intraoperative hypotension.
- Systematic review and meta-analysis of 87 RCTs enrolling 30,611 adults undergoing surgical, endoscopic, or dental procedures.
- Compared pEEG-guided with non-pEEG-guided anesthesia on anesthetic drug use, postoperative delirium, and perioperative efficiency measures.
- pEEG reduced propofol use (SMD -0.42) and volatile agent use (SMD -1.27), and postoperative delirium risk fell (RR 0.73, 95% CI 0.63 to 0.84).
- Extubation, wake-up, orientation, and PACU stay were all shorter with pEEG, with BIS showing the most consistent benefit and substantial heterogeneity for several outcomes.
- Systematic review and meta-analysis of five randomized trials, totaling 1613 adults aged 60 or older having surgery under regional anesthesia.
- Compared intraoperative dexmedetomidine with propofol, with delirium assessed using CAM or CAM-ICU.
- Delirium occurred in 7.7% of dexmedetomidine patients versus 16.7% with propofol (RR 0.48, 95% CI 0.36-0.64; P < .001), with low heterogeneity (I² = 13.4%).
- The authors conclude dexmedetomidine is associated with less postoperative delirium, and they rated the certainty of evidence as moderate by GRADE.
- This structured narrative review synthesizes adult postoperative delirium evidence across the perioperative pathway, searching major databases plus ESAIC and ASA resources and reference lists.
- It classifies prevention and therapeutic strategies by clinical maturity, target population, and implementation readiness rather than by pooled effect size.
- The authors report that no single anesthetic technique, processed-EEG target, blood-pressure threshold, cerebral oximetry strategy, or agent consistently prevents delirium across surgical populations.
- Multicomponent non-pharmacological prevention has the most consistent support, dexmedetomidine appears context-dependent, and biomarkers and metabolic targets remain investigational.
- Systematic review and meta-analysis of 13 RCTs including 1446 patients comparing preoperative cognitive training with usual care.
- Primary outcomes were postoperative delirium, delayed neurocognitive recovery, and postoperative neurocognitive disorder.
- Training was associated with lower postoperative delirium risk (RR 0.53, 95% CI 0.36-0.77, P=0.001), though certainty was rated low.
- The delayed neurocognitive recovery reduction (RR 0.66, 95% CI 0.46-0.96) was not robust to sensitivity analyses, and traditional training may outperform digital training for delirium.
- This mini review synthesizes a targeted search of pediatric esketamine studies covering analgesia, sedation, propofol injection pain, and emergence delirium or agitation.
- Randomized trials and meta-analyses generally report fewer emergence delirium or agitation events after low intravenous esketamine doses, mostly during sevoflurane adenotonsillectomy.
- Direct dose-comparison evidence in that setting shows increasing benefit up to 0.5 mg/kg intravenously, with no upper efficacy or safety boundary identified.
- The authors conclude that 0.2-0.5 mg/kg IV was the best-studied range for emergence prevention, not a validated therapeutic window, and call for direct dose-timing trials.